Photo taken from St. Baldrick’s Foundation/X
Jun 15, 2024, 03:33
Carvedilol in childhood cancer survivors who received Anthracyclines – St. Baldrick’s Foundation
St. Baldrick’s Foundation, shared a post on X:
“Anthracyclines, used for treating childhood cancer, may improve survival but can also cause heart failure. To reduce this risk, researchers tested carvedilol in childhood cancer survivors, research partly supported by St. Baldrick’s.
While safe, it didn’t significantly improve heart function overall but showed promise in long-time survivors. Further research is needed to strategize how survivors can better manage their heart health and you can help fund it.”
Additional information
Source: St. Baldrick’s Foundation/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 15:20
Nov 21, 2024, 14:56
Nov 21, 2024, 14:41
Nov 21, 2024, 13:55
Nov 21, 2024, 13:46
Nov 21, 2024, 13:25
Nov 21, 2024, 12:57